FDA approves new CDC test for influenza

Article

The US Food and Drug Administration (FDA) approved a test developed by the Centers for Disease Control and Prevention (CDC) used to diagnose influenza, including the H5N1 flu virus.

The US Food and Drug Administration (FDA) approved a test developed by the Centers for Disease Control and Prevention (CDC) used to diagnose influenza, including the H5N1 flu virus.

The test, called the Human Influenza Virus Real-Time RT-PCR Detection and Characterization Panel (rRT-PCR Flu Panel), can detect commonly circulating human influenza viruses, with results available within four hours.

The rRT-PCR Flu Panel can differentiate between seasonal and novel influenza. Viral genetic material taken from a patient's nose and throat using the device is then analyzed by a diagnostic instrument called the Applied Biosystems 7500 Fast Dx, which the FDA has also approved for use.

The rRT-PCR Flu Panel is meant to help enable the accuracy of influenza testing results among CDC-qualified laboratories, and will be available beginning this fall.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jillian Cotter, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.